# Program 1 Phase V5 - Prototype Limitations and Non-Approval Review

Phase V is intentionally limited.

## Limitations

- Prototype is not production access control.
- Prototype is not production auth/authz/RBAC.
- Prototype is not production audit logging.
- Prototype is not production-grade auditability.
- Prototype is not real-data governance approval.
- Prototype is not PHI/PII processing approval.
- Prototype is not validation evidence for production.
- Prototype is not legal/compliance approval.
- Prototype is not clinical safety approval.
- Prototype is not go-live authorization.
- Prototype is not workflow enforcement.
- Prototype is not an approval, clearance, or override mechanism.

## Non-approval review

| Boundary | Current status | Can Phase V lift it? |
| --- | --- | --- |
| production use | not approved | no |
| real patient data | not approved | no |
| PHI/PII processing | not approved | no |
| production auth/authz/RBAC | not implemented | no |
| production audit logging | not implemented | no |
| patient messaging | prohibited | no |
| appointment mutation | prohibited | no |
| clinical write workflow | prohibited | no |
| approval/clearance/override | prohibited | no |
| Task engine | prohibited | no |
| Outcome Evidence | prohibited | no |
| workflow enforcement | prohibited | no |
| go-live authorization | not granted | no |

The Phase V documents may help future planning, but they do not close a production-readiness, real-data, validation, legal, clinical safety, operational readiness, or go-live gate.
